x

Coronavirus

Bill Gates Expects a Coronavirus Vaccine to Get Regulatory Approval by Early Next Year

September 15, 2020

BERLIN — Billionaire philanthropist Bill Gates expects a coronavirus vaccine to get regulatory approval by early next year.

In a series of interviews with German media published Tuesday, the Microsoft co-founder suggested several vaccines might be available in 2021, but cautioned that the pandemic may not be over until 2022.

Gates, whose foundation supports vaccine development efforts, told the weekly Der Spiegel that he sees a slim chance that drugmakers Pfizer and Moderna might get enough data by the end of October to apply for emergency approval for their COVID-19 vaccines.

But he expressed confidence that of the vaccines being developed by the two companies and rivals AstraZeneca, Johnson & Johnson, Novavax and Sanofi, “three or four” would get emergency regulatory approval by the beginning of 2021.

RELATED

BEIJING (AP) — The hunt for the origins of COVID-19 has gone dark in China, the victim of political infighting after a series of stalled and thwarted attempts to find the source of the virus that killed millions and paralyzed the world for months.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

On Monday, April 22, 2024, history was being written in a Manhattan courtroom.

PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.

WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.